Aytu BioPharma, Inc. beat EPS estimates 0% of the time across 2 reported quarters (0 beats, 2 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q42026 FY2026 | $-0.22 | — | — | Miss |
| Q32026 FY2026 | $-0.31 | $-0.53 | -71.0% | Miss |
| Q22026 FY2026 | $-0.26 | $-1.05 | -303.9% | Miss |
Back to AYTU overview · AYTU holders · AYTU KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.